Article ISI SCOPUS
Cancer Immunology, Immunotherapy  (2013)

The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses

Duran-Aniotz, C; Segal G; Salazar, L; Pereda, C; Falcon, C; Tempio F.; Aguilera R.; González R.; Pérez, C.; Tittarelli, A; Catalan, D; Nervi, B; Larrondo M.; SALAZAR ONFRAY F; López MN

Más información

Título según WOS: The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
Título según SCOPUS: The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
Título de la Revista: Cancer Immunology, Immunotherapy
Volumen: 62
Número: 4
Editorial: Springer Science and Business Media Deutschland GmbH
Fecha de publicación: 2013
Página de inicio: 761
Página final: 772
Idioma: English
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84870819071&partnerID=40&md5=3aa6a8f127b60ebf590981d9a519e1cb
DOI:

10.1007/s00262-012-1377-3
Notas: ISI, SCOPUS